Preparation method of high-stability novel antioxidant enzyme-containing medicine for treating inflammatory enteritis

Abstract

The invention belongs to the technical field of enteritis treatment, and particularly relates to a preparation method of a high-stability novel antioxidant enzyme-containing medicine for treating inflammatory enteritis, and the preparation method of the high-stability novel antioxidant enzyme-containing medicine for treating inflammatory enteritis comprises the following steps: step 1, homogenizing glucan, fructo-oligosaccharide and galactooligosaccharide in a homogenizer; step 2, adding superoxide dismutase, vitamin C, bunge cherry seed powder, semen cassiae powder, turmeric, sorbitol, hydroxypropyl methyl cellulose, silicon dioxide and magnesium stearate into the homogenized material, and crushing; step 3, filtering the crushed material through a 60-mesh sieve; step 4, adding 1%-4% of water into the filtered material, and stirring; and step 5, tabletting and forming in an environment with the temperature of 10-30 DEG C and the humidity of 40% RH-55% RH. In the application document, the occurrence of local inflammation caused by activation of various cytokine reactions due to cellular reactions is reduced, and the damage to intestinal walls is reduced.

Description

technical field [0001] The invention relates to the technical field of enteritis treatment, in particular to a preparation method of a medicine containing a novel high-stable antioxidant enzyme for treating inflammatory enteritis. Background technique [0002] Inflammatory bowel disease is a chronic granulomatous disease of the gastrointestinal tract with unknown etiology. It is more common in the terminal ileum and adjacent colon. Ulcerative colitis, also known as nonspecific ulcerative colitis, is a chronic inflammatory disease of the rectum and colon of unknown cause. The lesions mainly involve the large intestinal mucosa and submucosa, and the rectum and distal colon are the most common affected sites, but the entire colon and terminal ileum can also be involved in severe lesions. Their manifestations are generally diarrhea, abdominal pain, and some people may even have bloody stools. At present, it is believed that the pathogenesis of inflammatory bowel disease may be...

AI Technical Summary

Problems solved by technology

Poor curative effect, large side effects, and prone to drug resistance

Images